"Your support makes all the difference. A daily pill commonly prescribed for rheumatoid arthritis and alopecia could also slow the progression of type 1 diabetes. The chronic disease, caused by the immune system mistakenly attacking insulin-producing cells in the pancreas, affects around 270,000 people living in England and many have to take lifelong insulin injections to help manage their blood sugar levels."
"But a two-year Australian trial found the drug Baricitinib - which works by blocking signals that lead to overactivity of the immune system - helps to protect the remaining insulin-producing cells in people who are newly diagnosed. Researchers believe this drug, which is already used to treat several autoimmune diseases, including rheumatoid arthritis, ulcerative colitis, and alopecia, could delay the progression of type 1 diabetes symptoms."
A two-year Australian trial demonstrated that Baricitinib can protect remaining insulin-producing pancreatic cells in people newly diagnosed with type 1 diabetes. Baricitinib works by blocking signals that lead to immune system overactivity and is already used to treat rheumatoid arthritis, ulcerative colitis, and alopecia. Type 1 diabetes results from the immune system mistakenly attacking insulin-producing cells and affects around 270,000 people in England, many of whom require lifelong insulin injections. An oral disease-modifying treatment administered early could delay symptom progression and reduce dependence on insulin therapy.
Read at www.independent.co.uk
Unable to calculate read time
Collection
[
|
...
]